BackAgile Therapeutics Overview

Agile Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for AGRX.

Quarterly EBIT

-$2.75M
↑ 46.27% YoY

As of Jun 30, 2024

Annual EBIT (TTM)

-$13.61M
↑ 48.2% YoY

Trailing 12 months ending Jun 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin